{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:59:37Z","timestamp":1790657977000,"version":"4.1.0"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of chronic liver disease worldwide, affecting approximately 38% of the global population. This network meta-analysis systematically compared the effects of different plant extracts on liver biochemical and non-invasive histological outcomes in patients with MASLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study was performed in accordance with the PRISMA guidelines and registered with PROSPERO (CRD420251229711). We systematically searched PubMed, Embase, Cochrane Library, and Web of Science up to November 12, 2025 for randomized controlled trials (RCTs) assessing plant extracts in adults with MASLD. Primary outcomes were alanine aminotransferase (ALT), aspartate aminotransferase (AST), controlled attenuation parameter (CAP), liver stiffness measurement (LSM), and hepatic steatosis percentage. Network meta-analyses were conducted using Stata 15.1 and R 4.2.1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 32 RCTs were included, involving 2,053 patients and 28 types of plant extracts. For liver enzyme outcomes, a novel curcumin preparation (CP) exhibited the highest ranking probability for ALT reduction (SUCRA: 91.93%), whereas cinnamon (Cin) ranked highest for AST reduction (SUCRA: 88.48%). For non-invasive histological outcomes, purslane (Pur) showed the greatest ranking probability for reducing LSM (SUCRA: 94.16%), while fenugreek (Fen) demonstrated favorable ranking probabilities for both CAP reduction (SUCRA: 79.07%) and hepatic steatosis percentage reduction (SUCRA: 86.97%). The overall methodological quality of the included studies was generally acceptable, and funnel plot assessments revealed no substantial evidence of publication bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Compared with placebo, most plant extracts do not achieve statistically significant improvements in liver biochemical or non-invasive liver-related outcomes, leaving their overall clinical efficacy uncertain. Although CP, Cin, Fen, and Pur showed favorable probability rankings for specific endpoints based on SUCRA values, these findings should not be interpreted as evidence of clinically meaningful superiority. Given the limited evidence, considerable heterogeneity, and uncertainty in comparative estimates, the current data do not support the use of plant extracts as standalone therapies for MASLD outside the context of concomitant lifestyle modification. Adequately powered, standardized RCTs are warranted to clarify their therapeutic effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251229711<\/jats:ext-link>\n                      ; Identifier: CRD420251229711.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1919204","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:39:43Z","timestamp":1790656783000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of plant extracts for metabolic dysfunction-associated steatotic liver disease: a network meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhenghong","family":"Xie","sequence":"first","affiliation":[{"name":"Medical School, Nantong University","place":["Nantong, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxing","family":"Chen","sequence":"additional","affiliation":[{"name":"Medical School, Nantong University","place":["Nantong, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1463-1326.2009.01132.x","article-title":"The effects of xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat","volume":"12","author":"Abidov","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e16652","DOI":"10.1016\/j.heliyon.2023.e16652","article-title":"Effects of one-year supplementation with Phyllanthus niruri on fibrosis score and metabolic markers in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial","volume":"9","author":"Abu Hassan","year":"2023","journal-title":"Heliyon"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.nutres.2013.11.005","article-title":"Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients","volume":"34","author":"Askari","year":"2014","journal-title":"Nutr. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4103\/ijp.IJP_17_19","article-title":"Comparison of the efficacy of oral fenugreek seeds hydroalcoholic extract versus placebo in nonalcoholic fatty liver disease; a randomized, triple-blind controlled pilot clinical trial","volume":"52","author":"Babaei","year":"2020","journal-title":"Indian J. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/978-1-62703-059-5_25","article-title":"Bayesian inference","volume":"930","author":"Bois","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.abb.2006.12.034","article-title":"Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes","volume":"459","author":"Cao","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1039\/c3fo60495k","article-title":"Hibiscus sabdariffa extract inhibits obesity and fat accumulation, and improves liver steatosis in humans","volume":"5","author":"Chang","year":"2014","journal-title":"Food Funct."},{"key":"B10","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1089\/jicm.2021.0362","article-title":"The efficacy of oligonol in nonalcoholic fatty liver disease: a randomized double-blinded placebo-controlled trial","volume":"28","author":"Chayanupatkul","year":"2022","journal-title":"J. Integr. Complement. Med."},{"key":"B11","volume-title":"Confidence in Network Meta-Analysis","year":"2020"},{"key":"B12","volume-title":"Heterogeneity: Subgroups, Meta-Regression, Bias and Bias-Adjustment","author":"Dias","year":"2012"},{"key":"B13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/0272989x12455847","article-title":"Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials","volume":"33","author":"Dias","year":"2013","journal-title":"Med. Decis. Mak."},{"key":"B14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.nutres.2014.09.005","article-title":"Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease","volume":"34","author":"Faghihzadeh","year":"2014","journal-title":"Nutr. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1017\/s0007114515002433","article-title":"The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study","volume":"114","author":"Faghihzadeh","year":"2015","journal-title":"Br. J. Nutr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3389\/fendo.2020.00494","article-title":"Randomized clinical trial: bergamot citrus and wild cardoon reduce liver steatosis and body weight in non-diabetic individuals aged over 50 years","volume":"11","author":"Ferro","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.3390\/medicina58121728","article-title":"Citrus bergamia and Cynara cardunculus reduce serum uric acid in individuals with non-alcoholic fatty liver disease","volume":"58","author":"Ferro","year":"2022","journal-title":"Med. Kaunas."},{"key":"B18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3945\/an.114.007807","article-title":"Diosgenin, 4-hydroxyisoleucine, and fiber from fenugreek: mechanisms of actions and potential effects on metabolic syndrome","volume":"6","author":"Fuller","year":"2015","journal-title":"Adv. Nutr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12906-024-04477-3","article-title":"The effects of grape seed extract supplementation on cardiovascular risk factors, liver enzymes and hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study","volume":"24","author":"Ghanbari","year":"2024","journal-title":"BMC Complement. Med. Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/ije\/dyt043","article-title":"Markov chain monte carlo: an introduction for epidemiologists","volume":"42","author":"Hamra","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.7762\/cnr.2020.9.4.258","article-title":"A randomized, double-blind, placebo-controlled, multi-centered clinical study to evaluate the efficacy and safety of Artemisia annua L. extract for improvement of liver function","volume":"9","author":"Han","year":"2020","journal-title":"Clin. Nutr. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3390\/nu17030453","article-title":"Evaluating bioactive-substance-based interventions for adults with MASLD: results from a systematic scoping review","volume":"17","author":"Handu","year":"2025","journal-title":"Nutrients"},{"key":"B23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jgr.2020.07.004","article-title":"Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function","volume":"45","author":"Hong","year":"2021","journal-title":"J. Ginseng Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.23751\/pn.v21i2-S.7267","article-title":"Effects of green coffee extract supplementation on blood pressure and antioxidants status in patients with non-alcoholic fatty liver disease","volume":"21","author":"Hosseinabadi","year":"2019","journal-title":"Prog. Nutr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"931","DOI":"10.12669\/pjms.334.12571","article-title":"Therapeutic benefits of green tea extract on various parameters in non-alcoholic fatty liver disease patients","volume":"33","author":"Hussain","year":"2017","journal-title":"Pak J. Med. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/m14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e25067","DOI":"10.5812\/hepatmon.25067","article-title":"The effect of Berberis vulgaris extract on transaminase activities in non-alcoholic fatty liver disease","volume":"15","author":"Iloon Kashkooli","year":"2015","journal-title":"Hepat. Mon."},{"key":"B29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/ptr.6826","article-title":"Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: a double-blind randomized controlled clinical trial","volume":"35","author":"Izadi","year":"2021","journal-title":"Phytother. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"102693","DOI":"10.1016\/j.dsx.2022.102693","article-title":"Effectiveness of the pomegranate extract in improving hepatokines and serum biomarkers of non-alcoholic fatty liver disease: a randomized double blind clinical trial","volume":"17","author":"Jafarirad","year":"2023","journal-title":"Diabetes Metab. Syndr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.3390\/nu14142921","article-title":"Litchi-derived polyphenol alleviates liver steatosis and gut dysbiosis in patients with non-alcoholic fatty liver disease: a randomized double-blinded, placebo-controlled study","volume":"14","author":"Jinato","year":"2022","journal-title":"Nutrients"},{"key":"B32","doi-asserted-by":"publisher","first-page":"111489","DOI":"10.1016\/j.cbi.2025.111489","article-title":"Flavonoids and their role in oxidative stress, inflammation, and human diseases","volume":"413","author":"Jomova","year":"2025","journal-title":"Chem. Biol. Interact."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis","volume":"159","author":"Lassailly","year":"2020","journal-title":"Gastroenterology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3350\/cmh.2022.0239","article-title":"Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach","volume":"28","author":"Le","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1089\/jmf.2021.K.0069","article-title":"Artichoke extract directly suppresses inflammation and apoptosis in hepatocytes during the development of non-alcoholic fatty liver disease","volume":"24","author":"Lee","year":"2021","journal-title":"J. Med. Food"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1751583","DOI":"10.1155\/2018\/1751583","article-title":"The effect of a hydrolyzed polysaccharide dietary supplement on biomarkers in adults with nonalcoholic fatty liver disease","volume":"2018","author":"Lewis","year":"2018","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"142391","DOI":"10.1016\/j.foodchem.2024.142391","article-title":"Polyphenols-rich Portulaca oleracea L. (purslane) alleviates ulcerative colitis through restiring the intestinal barrier, gut microbiota and metabolites","volume":"468","author":"Li","year":"2025","journal-title":"Food Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1002\/ptr.8182","article-title":"Effects of different natural products in patients with non-alcoholic fatty liver disease-A network meta-analysis of randomized controlled trials","volume":"38","author":"Liu","year":"2024","journal-title":"Phytother. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"112294","DOI":"10.1016\/j.nut.2023.112294","article-title":"A nutraceutical with citrus bergamia and Cynara cardunculus improves endothelial function in adults with non-alcoholic fatty liver disease","volume":"118","author":"Maurotti","year":"2024","journal-title":"Nutrition"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1371137","DOI":"10.3389\/fnut.2024.1371137","article-title":"Effects of Portulaca oleracea (purslane) on liver function tests, metabolic profile, oxidative stress and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: a randomized, double-blind clinical trial","volume":"11","author":"Milkarizi","year":"2024","journal-title":"Front. Nutr."},{"key":"B41","doi-asserted-by":"publisher","first-page":"f2914","DOI":"10.1136\/bmj.f2914","article-title":"Demystifying trial networks and network meta-analysis","volume":"346","author":"Mills","year":"2013","journal-title":"Bmj"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.3390\/nu14163434","article-title":"Bergamot polyphenol extract reduces hepatocyte neutral fat by increasing beta-oxidation","volume":"14","author":"Mirarchi","year":"2022","journal-title":"Nutrients"},{"key":"B43","doi-asserted-by":"publisher","first-page":"100190","DOI":"10.1016\/j.metop.2022.100190","article-title":"Effect of 8 weeks milk thistle powder (silymarin extract) supplementation on fatty liver disease in patients candidates for bariatric surgery","volume":"14","author":"Mirhashemi","year":"2022","journal-title":"Metabol. Open"},{"key":"B44","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jtcme.2020.02.004","article-title":"The synergistic effect of citrus bergamia and Cynara cardunculus extracts on vascular inflammation and oxidative stress in non-alcoholic fatty liver disease","volume":"10","author":"Musolino","year":"2020","journal-title":"J. Tradit. Complement. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/hep.0000000000000937","article-title":"Effect of phospholipid curcumin meriva on liver histology and kidney disease in nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial","volume":"81","author":"Musso","year":"2025","journal-title":"Hepatology"},{"key":"B46","first-page":"454","article-title":"Efficacy of Cichorium intybus on alanine aminotransferase in nonalcoholic fatty liver disease: a randomised double-blind clinical trial with placebo","volume":"8","author":"Nikkhajoei","year":"2016","journal-title":"Biol. Forum Int. J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1080","DOI":"10.1002\/cl2.1080","article-title":"CINeMA: software for semiautomated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"Papakonstantinou","year":"2020","journal-title":"Campbell Syst. Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"100165","DOI":"10.1016\/j.obmed.2019.100165","article-title":"The effects of crocus sativus extract on serum lipid profile and liver enzymes in patients with non-alcoholic fatty liver disease: a randomized placebo-controlled study","volume":"17","author":"Parsi","year":"2020","journal-title":"Obes. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"218","DOI":"10.22377\/ijgp.v17i03.3472","article-title":"Evaluation of the safety and efficacy of CurcuVail\u00ae in patients with non-alcoholic fatty liver disease - a prospective randomized, double blind, placebo controlled, parallel group study","volume":"17","author":"Patel","year":"2023","journal-title":"Int. J. Green Pharm."},{"key":"B51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4103\/2008-7802.173051","article-title":"The effect of green tea extract supplementation on liver enzymes in patients with nonalcoholic fatty liver disease","volume":"7","author":"Pezeshki","year":"2016","journal-title":"Int. J. Prev. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"361","DOI":"10.31989\/ffhd.v12i7.958","article-title":"A blend of Sphaeranthus indicus flower head and Terminalia chebula fruit extracts reduces fatty liver and improves liver function in non-alcoholic, overweight adults","volume":"12","author":"Rajendra","year":"2022","journal-title":"Funct. Foods Health Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med. Res. Methodol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"101040","DOI":"10.1016\/j.gastha.2026.101040","article-title":"Comparative efficacy of herbal products on metabolic parameters in MASLD: a systematic review and network meta-analysis","volume":"5","author":"Sairaj","year":"2026","journal-title":"Gastro Hep Adv."},{"key":"B56","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.1002\/ptr.7199","article-title":"The effect of (cornus mas L.) fruit extract on liver function among patients with nonalcoholic fatty liver: a double-blind randomized clinical trial","volume":"35","author":"Sangsefidi","year":"2021","journal-title":"Phytother. Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12035-011-8181-5","article-title":"Modulation of Nrf2\/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders","volume":"44","author":"Scapagnini","year":"2011","journal-title":"Mol. Neurobiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e12299","DOI":"10.5812\/hepatmon.45609","article-title":"Effects of green coffee bean extract supplementation on patients with non-alcoholic fatty liver disease: a randomized clinical trial","volume":"17","author":"Shahmohammadi","year":"2017","journal-title":"Hepat. Mon."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2185\/jrm.2023-026","article-title":"Barriers to lifestyle modification in patients with non-alcoholic fatty liver disease: a scoping review","volume":"19","author":"Shibayama","year":"2024","journal-title":"J. Rural. Med."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.10.042","article-title":"Bioactivity and multi-omics profiling of purslane-derived nanovesicles with therapeutic implications in diabetic wounds","author":"Song","year":"2025","journal-title":"J. Adv. Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/1467-9868.00353","article-title":"Bayesian measures of model complexity and fit","volume":"64","author":"Spiegelhalter","year":"2002","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"key":"B64","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"Tacke","year":"2024","journal-title":"J. Hepatol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"666","DOI":"10.7326\/m15-2521","article-title":"Uncertainty in treatment rankings: reanalysis of network meta-analyses of randomized trials","volume":"164","author":"Trinquart","year":"2016","journal-title":"Ann. Intern Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12936-017-1963-0","article-title":"Comparison of anti-malarial drugs efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis","volume":"16","author":"Whegang","year":"2017","journal-title":"Malar. J."},{"key":"B67","doi-asserted-by":"publisher","first-page":"949746","DOI":"10.3389\/fimmu.2022.949746","article-title":"Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"6890","DOI":"10.3748\/wjg.v22.i30.6890","article-title":"Herbal medicines and nonalcoholic fatty liver disease","volume":"22","author":"Yao","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/hep.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ctim.2018.09.010","article-title":"The effects of Zataria multiflora boiss. (shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: a randomized double-blind placebo-controlled clinical trial","volume":"41","author":"Zamani","year":"2018","journal-title":"Complement. Ther. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1919204\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:40:07Z","timestamp":1790656807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1919204\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":70,"alternative-id":["10.3389\/fphar.2026.1919204"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1919204","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"article-number":"1919204"}}